Attached files

file filename
10-K - ANNUAL REPORT - MERIDIAN BIOSCIENCE INCd472698d10k.htm
EX-32 - EX-32 - MERIDIAN BIOSCIENCE INCd472698dex32.htm
EX-31.2 - EX-31.2 - MERIDIAN BIOSCIENCE INCd472698dex312.htm
EX-31.1 - EX-31.1 - MERIDIAN BIOSCIENCE INCd472698dex311.htm
EX-21 - EX-21 - MERIDIAN BIOSCIENCE INCd472698dex21.htm
EX-13 - EX-13 - MERIDIAN BIOSCIENCE INCd472698dex13.htm
EX-10.16.9 - EX-10.16.9 - MERIDIAN BIOSCIENCE INCd472698dex10169.htm
EX-10.16.8 - EX-10.16.8 - MERIDIAN BIOSCIENCE INCd472698dex10168.htm
EX-10.13 - EX-10.13 - MERIDIAN BIOSCIENCE INCd472698dex1013.htm
EX-10.12 - EX-10.12 - MERIDIAN BIOSCIENCE INCd472698dex1012.htm
EX-10.11 - EX-10.11 - MERIDIAN BIOSCIENCE INCd472698dex1011.htm
EX-10.10 - EX-10.10 - MERIDIAN BIOSCIENCE INCd472698dex1010.htm
EX-10.9 - EX-10.9 - MERIDIAN BIOSCIENCE INCd472698dex109.htm

Exhibit 23

Consent of Independent Registered Public Accounting Firm

We have issued our reports dated November 29, 2017, with respect to the consolidated financial statements, schedule, and internal control over financial reporting included in the Annual Report of Meridian Bioscience, Inc. on Form 10-K for the year ended September 30, 2017. We consent to the incorporation by reference of said reports in the Registration Statements of Meridian Bioscience, Inc. on Form S-3ASR (File No. 333-200645), and on Forms S-8 (File No. 333-179440, File No. 333-155703, File No. 333-122554, File No. 333-75312, and File No. 333-74825).

/s/ GRANT THORNTON LLP

Cincinnati, Ohio

November 29, 2017